The addition of tests highly specific for anti-KLHL12 antibodies to AMA and ANA serological assays significantly improves the efficacy of clinical detection and diagnosis of PBC, especially for AMA M2-negative subjects. The gene discussed is BTG3; the disease is primary biliary cholangitis.